Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Study commences to evaluate long-term benefit of chronic hepatitis C treatment

Aug. 10, 2000

Zadaxin receives expanded marketing approval in Argentina

Aug. 10, 2000

Forest licenses dexloxiglumide from Rotta for treatment of IBS

Aug. 8, 2000

SciClone begins marketing and distribution of Zadaxin in Mexico

Aug. 7, 2000

Mitsubishi Chemical patents amide derivatives active against H. pylori

Aug. 4, 2000

FDA grants orphan drug status to ALX-0600 as treatment of short bowel syndrome

Aug. 4, 2000

Antex evaluates dosing schedule in phase Ib/II trial of Helivax

July 28, 2000

Antiviral action of aciclovir lipid prodrug assessed against woodchuck hepatitis virus

July 28, 2000

Salix's Colazal approved in U.S. for ulcerative colitis

July 27, 2000

Antiinflammatory profile of ridogrel examined in inflamed colorectal mucosal biopsies

July 27, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...